276 related articles for article (PubMed ID: 12000722)
1. The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease.
Lewindon PJ; Pereira TN; Hoskins AC; Bridle KR; Williamson RM; Shepherd RW; Ramm GA
Am J Pathol; 2002 May; 160(5):1705-15. PubMed ID: 12000722
[TBL] [Abstract][Full Text] [Related]
2. Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia.
Ramm GA; Nair VG; Bridle KR; Shepherd RW; Crawford DH
Am J Pathol; 1998 Aug; 153(2):527-35. PubMed ID: 9708812
[TBL] [Abstract][Full Text] [Related]
3. The role of Smad3 in mediating mouse hepatic stellate cell activation.
Schnabl B; Kweon YO; Frederick JP; Wang XF; Rippe RA; Brenner DA
Hepatology; 2001 Jul; 34(1):89-100. PubMed ID: 11431738
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta1 in plasma and liver of children with liver disease.
Rosensweig JN; Omori M; Page K; Potter CJ; Perlman EJ; Thorgeirsson SS; Schwarz KB
Pediatr Res; 1998 Sep; 44(3):402-9. PubMed ID: 9727721
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of transforming growth factor-beta1 and thrombospondin-1 in congenital hepatic fibrosis: possible role of the hepatic stellate cell.
El-Youssef M; Mu Y; Huang L; Stellmach V; Crawford SE
J Pediatr Gastroenterol Nutr; 1999 Apr; 28(4):386-92. PubMed ID: 10204502
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats.
Arias M; Sauer-Lehnen S; Treptau J; Janoschek N; Theuerkauf I; Buettner R; Gressner AM; Weiskirchen R
BMC Gastroenterol; 2003 Oct; 3():29. PubMed ID: 14565855
[TBL] [Abstract][Full Text] [Related]
7. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
8. Connective tissue growth factor in human liver cirrhosis.
Abou-Shady M; Friess H; Zimmermann A; di Mola FF; Guo XZ; Baer HU; Büchler MW
Liver; 2000 Jul; 20(4):296-304. PubMed ID: 10959808
[TBL] [Abstract][Full Text] [Related]
9. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats.
Yasuda H; Imai E; Shiota A; Fujise N; Morinaga T; Higashio K
Hepatology; 1996 Sep; 24(3):636-42. PubMed ID: 8781336
[TBL] [Abstract][Full Text] [Related]
10. Gremlin1 Accelerates Hepatic Stellate Cell Activation Through Upregulation of TGF-Beta Expression.
Zhang YQ; Wan LY; He XM; Ni YR; Wang C; Liu CB; Wu JF
DNA Cell Biol; 2017 Jul; 36(7):603-610. PubMed ID: 28467108
[TBL] [Abstract][Full Text] [Related]
11. CFTR dysfunction predisposes to fibrotic liver disease in a murine model.
Martin CR; Zaman MM; Ketwaroo GA; Bhutta AQ; Coronel E; Popov Y; Schuppan D; Freedman SD
Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(4):G474-81. PubMed ID: 22679000
[TBL] [Abstract][Full Text] [Related]
12. Systemic mediators induce fibrogenic effects in normal liver after partial bile duct ligation.
Osawa Y; Seki E; Adachi M; Taura K; Kodama Y; Siegmund SV; Schwabe RF; Brenner DA
Liver Int; 2006 Nov; 26(9):1138-47. PubMed ID: 17032415
[TBL] [Abstract][Full Text] [Related]
13. Expression of collagens type I and IV, osteonectin and transforming growth factor beta-1 (TGFbeta1) in biliary atresia and paucity of intrahepatic bile ducts during infancy.
Lamireau T; Le Bail B; Boussarie L; Fabre M; Vergnes P; Bernard O; Gautier F; Bioulac-Sage P; Rosenbaum J
J Hepatol; 1999 Aug; 31(2):248-55. PubMed ID: 10453937
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional basis for hepatic fibrosis in cystic fibrosis-associated liver disease.
Pereira TN; Lewindon PJ; Greer RM; Hoskins AC; Williamson RM; Shepherd RW; Ramm GA
J Pediatr Gastroenterol Nutr; 2012 Mar; 54(3):328-35. PubMed ID: 22157922
[TBL] [Abstract][Full Text] [Related]
15. Increased transforming growth factor-beta 1 gene expression in human liver disease.
Annoni G; Weiner FR; Zern MA
J Hepatol; 1992 Mar; 14(2-3):259-64. PubMed ID: 1380023
[TBL] [Abstract][Full Text] [Related]
16. Growth factor and procollagen type I gene expression in human liver disease.
Malizia G; Brunt EM; Peters MG; Rizzo A; Broekelmann TJ; McDonald JA
Gastroenterology; 1995 Jan; 108(1):145-56. PubMed ID: 7806036
[TBL] [Abstract][Full Text] [Related]
17. Effect of IL-10 on the expression of HSC growth factors in hepatic fibrosis rat.
Shi MN; Zheng WD; Zhang LJ; Chen ZX; Wang XZ
World J Gastroenterol; 2005 Aug; 11(31):4788-93. PubMed ID: 16097045
[TBL] [Abstract][Full Text] [Related]
18. DLPC decreases TGF-beta1-induced collagen mRNA by inhibiting p38 MAPK in hepatic stellate cells.
Cao Q; Mak KM; Lieber CS
Am J Physiol Gastrointest Liver Physiol; 2002 Nov; 283(5):G1051-61. PubMed ID: 12381518
[TBL] [Abstract][Full Text] [Related]
19. Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis.
Sedlaczek N; Jia JD; Bauer M; Herbst H; Ruehl M; Hahn EG; Schuppan D
Am J Pathol; 2001 Apr; 158(4):1239-44. PubMed ID: 11290541
[TBL] [Abstract][Full Text] [Related]
20. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
